Skip to main content

Market Overview

53 Biggest Movers From Friday



  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares jumped 34% to close at $9.65 on Friday.
  • NanoViricides, Inc. (NYSE: NNVC) shares rose 32.8% to close at $3.40.
  • Yuma Energy, Inc. (NYSE: YUMA) shares surged 28.7% to close at $3.95 on Friday amid crude oil which was up more than 3.5% to over the $63/barrel level. Traders have targeted this name previously given volatility in oil markets; the company has a float of just over 1 million shares, making it susceptible to increased volatility.
  • Nymox Pharmaceutical Corporation (NASDAQ: NYMX) shares gained 26.6% to close at $2.95 on Friday.
  • BioXcel Therapeutics, Inc. (NASDAQ: BTAI) rose 22.9% to close at $16.71.
  • U.S. Energy Corp. (NASDAQ: USEG) gained 22.6% to close at $0.38. U.S. Energy announced a 1-for-10 reverse stock split effective January 6.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose 21.1% to close at $0.2603.
  • Pacific Drilling S.A. (NYSE: PACD) surged 16.4% to close at $4.75.
  • LAIX Inc. (NYSE: LAIX) gained 16.4% to close at $5.61
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares gained 15.8% to close at $2.27 after Point72 reported a 9.8% passive stake in the company.
  • Extraction Oil & Gas, Inc. (NASDAQ: XOG) rose 14.2% to close at $2.41.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) surged 13.8% to close at $5.19. Chembio Diagnostics said it anticipates FDA approval for its DPP HIV-Syphilis System, which includes the DPP HIV-Syphilis test and DPP Micro Reader, during the first quarter of 2020. The company added its clinical study demonstrated that the system met the performance requirements established with the FDA.
  • Cinedigm Corp (NASDAQ: CIDM) shares gained 13.4% to close at $0.8166 after the company signed a definitive stock purchase agreement to acquire a 29% stake in Starrise Media.
  • Eros International Plc (NYSE: EROS) climbed 13.2% to close at $3.94.
  • Can-Fite BioPharma Ltd. (NYSE: CANF) rose 12.8% to close at $3.52 after the company announced pre-clinical data from the Hadassah Medical Center lab demonstrate that Namodenoson induces weight loss.
  • Yunji Inc. (NASDAQ: YJ) surged 12.7% to close at $5.05.
  • Microbot Medical Inc. (NASDAQ: MBOT) rose 12.1% to close at $11.59
  • Lamb Weston Holdings, Inc. (NYSE: LW) gained 11.3% to close at $93.56 after the company reported better-than-expected Q2 results and raised FY20 adjusted EBITDA guidance.
  • Caladrius Biosciences, Inc. (NASDAQ: CLBS) shares rose 11.1% to close at $2.80.
  • Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) surged 10.9% to close at $20.42.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 10.1% to close at $4.35.
  • California Resources Corporation (NYSE: CRC) rose 9.9% to close at $10.52 after the U.S. confirmed an airstrike that killed a top Iranian commander. The death of Soleimani has raised geopolitical concerns in the Middle East, causing oil prices to rise.
  • Valaris plc (NYSE: VAL) surged 9.8% to close at $7.42. Fearnleys upgraded Valaris from Hold to Buy.
  • Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) rose 9.5% to close at $12.25.
  • Kezar Life Sciences, Inc. (NASDAQ: KZR) gained 9.4% to close at $3.91.
  • Himax Technologies, Inc. (NASDAQ: HIMX) rose 9.3% to close at $3.06.
  • Whiting Petroleum Corporation (NYSE: WLL) shares gained 8.6% to close at $7.85.
  • SeaSpine Holdings Corporation (NASDAQ: SPNE) climbed 8.2% to close at $12.51.
  • Oasis Petroleum Inc. (NASDAQ: OAS) rose 7.2% to close at $3.44.
  • DURECT Corporation (NASDAQ: DRRX) gained 7.1% to close at $2.80.
  • W&T Offshore, Inc. (NYSE: WTI) rose 7% to close at $5.80 after the U.S. confirmed an airstrike that killed a top Iranian commander. The death of Soleimani has raised geopolitical concerns in the Middle East, causing oil prices to rise.
  • Camber Energy, Inc. (NYSE: CEI) shares gained 6.5% to close at $1.81 after falling 10.99% on Thursday.

Check out these big penny stock gainers and losers


  • Novan, Inc. (NASDAQ: NOVN) shares tumbled 73.1% to close at $0.8380 on Friday. Novan released top-line efficacy results from the Phase 3 B-SIMPLE program that evaluated SB206 for the treatment of molluscum contagiosum, which showed that statistical significance was not achieved for the primary endpoint in either B-SIMPLE1 or B-SIMPLE2.
  • DPW Holdings, Inc. (NYSE: DPW) declined 36.7% to close at $1.52 after rising 101.65% on Thursday.
  • Synthesis Energy Systems, Inc. (NASDAQ: SES) declined 22.5% to close at $8.83 after rising 100.00% on Thursday.
  • Mereo BioPharma Group plc (NASDAQ: MREO) dropped 12.5% to close at $2.81.
  • NeuroMetrix, Inc. (NASDAQ: NURO) tumbled 11.2% to close at $3.82.
  • China Rapid Finance Limited (NYSE: XRF) dropped 10.3% to close at $3.30.
  • Landec Corporation (NASDAQ: LNDC) shares fell 10.2% to close at $10.03 after the company reported a wider-than-expected loss for its second quarter.
  • Veoneer, Inc. (NYSE: VNE) dropped 9.9% to close at $14.52.
  • Abeona Therapeutics Inc. (NASDAQ: ABEO) shares fell 9.7% to close at $2.90.
  • Aprea Therapeutics, Inc. (NASDAQ: APRE) dipped 9.5% to close at $41.00.
  • Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) fell 9.4% to close at $6.07.
  • Incyte Corporation (NASDAQ: INCY) fell 9.4% to close at $77.90 after the company disclosed that Itacitinib did not statistically improve overall response rate or non-relapse mortality compared to placebo in Phase 3 study.
  • Enochian Biosciences Inc. (NASDAQ: ENOB) fell 9.2% to close at $4.73.
  • Ruhnn Holding Limited (NASDAQ: RUHN) dipped 9.1% to close at $7.89.
  • Cue Biopharma, Inc. (NASDAQ: CUE) fell 9.1% to close at $14.83.
  • Homology Medicines, Inc. (NASDAQ: FIXX) tumbled 9% to close at $18.69.
  • Cortexyme, Inc. (NASDAQ: CRTX) fell 8.9% to close at $48.50.
  • Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) dropped 8.4% to close at $10.85.
  • Viveve Medical, Inc. (NASDAQ: VIVE) dropped 8.2% to close at $1.01 in sympathy with the overall market after a U.S. airstrike killed Iranian Major-General Qasem Soleimani.
  • Anavex Life Sciences Corp. (NASDAQ: AVXL) dipped 7.7% to close at $2.65.
  • Recon Technology, Ltd. (NASDAQ: RCON) slipped 6.6% to close at $2.69.

Related Articles (ACOR + ABEO)

View Comments and Join the Discussion!

Posted-In: Movers From FridayNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at